A support group for people suffering and affected from multiple Myeloma is held every third Saturday of every month in the San Francisco bay area. It caters for the families who have patients with multiple Myeloma, their friends and loved ones. This group shares what they know about the disease. Everything from the symptoms, the side effects, the diagnosis of the illness, the quality of life that is to be expected, and any other factor related to the disease. In case there is any advancement made with regard to the diseases, the members are made aware immediately. This particular meeting took place at South San Francisco medical center, Kaiser on November 15th, 2014.
The event was generally well attended by the people who are affected by the diseases and some who were curious about it. The speaker at this meeting was Dr. Tom Martin, a specialist in the field. His speech was about "New Agents in Multiple Myeloma Clinical Trials for 2014, including UCSF trials." The speaker eloquently described how the trials have been proceeding and how far these tests have reached. Since trials are a very sensitive subject to the patients, it was important for them to understand what exactly they entail.
Dr. Tom Martin was dressed officially and had a file that had all the resources he would need. He spoke eloquently and audibly with empathy and experience. His speech was informative and quite encouraging. It helped that he was a specialist and knew in depth what he was talking about in the support group. Even though he was speaking about trials not mainstream public treatments, his speech brought hope to the relapsed patients and the families who had attended the meeting. He engaged the audience and even made some jokes that lightened up the mood of the audience.
His anecdotes were not only humorous, but were related to the audience. The stories gave the listeners a chance to ask questions and then get answers from a professional doctor as well as from the audience itself. Despite talking about a disease, he always wore a smile that put the whole public at ease. He maintained a sense of positivity and engaged the audience efficiently when he was answering their questions. He never went too deep into a patient’s detail when he was answering the questions; he always maintained a sense of privacy and was a courteous and an attentive speaker.
In the future, I recommend that the speaker study his audience more intently. It is vital to thoroughly understand the people you will be talking to in the meeting. The audience contained some people who were not sick, but they were simply curious students. He was not able to really connect with them because he was talking more about the experiences and the expectations of the clinical trials. The students were curious to know the biology and chemistry that was going in the trials, but unfortunately they were disappointed.
Though it may be difficult to know exactly who the audience is, it is possible to view the people listening to you through their physical appearance. The way the audience is dressed determines their age. Additionally, the speech took longer than expected. Every seminar is meant to take three hours, but this time it went a little over three hours. At the end of the speech, it seemed like the doctor was rushing over some points in order not to extend longer to the time limit. It is essential that the next time he gives another speech, he can organize himself in order to fit perfectly in the time slot he is given. When he observes time, he can finish the speech when he is relaxed and satisfied that his audience has gained the purpose of the meeting.